Original BioMedicals Company Description

Original BioMedicals Co., Ltd. engages in the development of drugs in Taiwan.

The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries, including nuclear radiation and solar radiation exposure in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for the treatment of iron deficiency.

It also provides NE (vitamin C+E) and NE Butorphanol, as well as technical services. Original BioMedicals Co., Ltd. was incorporated in 2011 and is based in Tainan City, Taiwan.

Original BioMedicals Co., Ltd.

Country	Taiwan
Founded	2011
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	25
CEO	Cliff C. Wang

Contact Details

Address: No. 9, Nanke 2nd Road Tainan City, 744092 Taiwan
Phone	886 6 505 5433
Website	i-obm.com

Stock Details

Ticker Symbol	6483
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006483001
SIC Code	2836

Key Executives

Name	Position
Dr. Cliff C. Wang Ph.D.	Chief Executive Officer, CRO and Director
Lawrence H. T. Tang	Chief Financial Officer
Hsiao-Pao Yen	Chief Operating Officer and Director
Cai Ling Liao	Accounting Supervisor
Duncan Chen MS	Chief Technology Officer and Director
Cecilia Hung	Director of Development
Dr. Alan Liss Ph.D.	Senior Vice President
Gan Xiao Ping	Head of Clinical Research Department